Virtual Clinical Trials Market Insights 2025-2034: Growth Forecast and Strategic Priorities

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Virtual Clinical Trials Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for virtual clinical trials has seen substantial growth in the past few years. The predictions point to an increase from $11.91 billion in 2024 to $12.99 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.0%. The historical growth can be credited to the rise in clinical trial costs, an escalating need for patient-oriented trials, a surge in demand for remote monitoring, wider usage of digital technologies in clinical trials, and a mounting requirement for efficient and cost-effective clinical trials.

Virtual Clinical Trials Market Size Forecast: What's the Projected Valuation by 2029?
There is an anticipated surge in the market size of virtual clinical trials in the coming years. The market is projected to expand to $19.67 billion by 2029, with a compound annual growth rate of 10.9%. The expansion during the forecasted period is associated with a heightened adoption rate of decentralized clinical trials, a rise in wearable and remote monitoring device usage, the extension of telehealth services, regulatory backing for virtual trial methodologies, and time and cost-efficient trials. The forthcoming trends include the increased application of artificial intelligence and machine learning in clinical trials, boosted use of electronic informed consent (econsent), expansion in virtual trial technologies and platforms, collaborations between tech providers and pharmaceutical companies, and a focus on real-world evidence and decentralized data compilation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

What Are the Drivers Transforming the Virtual Clinical Trials Market?
The surge in the virtual clinical trials market can be attributed to the growing investments by the government and pharmaceutical companies in research and development for the creation of new drugs and vaccines. As a means to enhance the quality control process and clinical data handling of drugs and their derivatives, medical industry's research and development sections continue to employ virtual clinical trial solutions and services. As per an article by McKinsey, the COVID-19 outbreak has speeded up the implementation of decentralized clinical trials among pharmaceutical companies. This not only sheds light on the crucial advantages of virtual trials but also enhances patient and doctor experiences. Hence, the rise in investments by the government and pharmaceutical companies in the development of new drugs and vaccines fuels the expansion of the virtual clinical trials market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6362&type=smp

What Long-Term Trends Will Define the Future of the Virtual Clinical Trials Market?
The enhancement of technology is an emerging trend that is swiftly gaining traction in the virtual clinical trials market. Major firms in this field are dedicating their resources to offer more technologically progressive solutions in order to accommodate the rapidly evolving demands of the industry and to solidify their standing in the market. New generation virtual clinical trial technologies like wearable technologies, mHealth, blockchain, cloud computing, EMR integration, actionable data, threshold monitoring, AI, SFTP, ETL services, among others, are being incorporated into their offerings. As a case in point, Unlearn.AI, a startup based in the United States, plans to release a new digital twin RCTs technology for clinical trials in April 2022. This technology allows for smaller control groups while still providing power and generating evidence that can support regulatory decisions, using AI and historical data.

Which Segments in the Virtual Clinical Trials Market Offer the Most Profit Potential?
The virtual clinical trials market covered in this report is segmented -

1) By Design: Observational Trials, Interventional Trials, Expanded Access Trials
2) By Phases: Phase I, Phase II, Phase III, Phase IV
3) By Indication: CNS, Autoimmune Or Inflammation, Cardiovascular Disease, Metabolic Or Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Other Indications

Subsegments:
1) By Observational Trials: Prospective Cohort Studies, Retrospective Studies, Case-Control Studies
2) By Interventional Trials: Randomized Controlled Trials (RCTs), Non-Randomized Trials, Adaptive Trials
3) By Expanded Access Trials: Single-Patient Expanded Access, Multi-Patient Expanded Access, Compassionate Use Programs

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6362&type=smp

Which Firms Dominate the Virtual Clinical Trials Market by Market Share and Revenue in 2025?
Major companies operating in the virtual clinical trials market include ICON plc, Parexel International Pvt. Ltd., IQVIA Holdings Inc., Covance Research Products Inc., Pharmaceutical Research Associates Inc., Medidata Solution Inc., Oracle Corporation, Clario Tech Ltd., Medable Inc., Science 37 Holdings Inc., THREAD Research, Clinical Ink Inc., Veeva Systems Inc., Clinerion Ltd., CRF Health Group Limited, Royal Castor Products Limited, Crio Inc., Deep Lens Inc., Florence Healthcare Inc., goBalto Inc., Medrio Inc., Mint Medical Ltd., Mytrus Inc., OpenClinica LLC, PatientWing, RealTime-CTMS LLC, Reify Health, Sanguine Biosciences Inc., TriNetX Inc., VirTrial LLC

Which Regions Offer the Highest Growth Potential in the Virtual Clinical Trials Market?
North America was the largest region in the virtual clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6362

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.